Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13769417 | 0.92 | LTC4S (0.34) | MEN1KMT2AALDH1A1GAAPDE4A | |
| SCHEMBL12713205 | 0.92 | ALDH1A1 (0.34) | MEN1KMT2AALDH1A1GAALMNA | |
| SCHEMBL1610550 | 0.86 | ALDH1A1 (0.41) | MEN1KMT2AALDH1A1MAPTNPSR1 | |
| SCHEMBL12738212 | 0.85 | MEN1 (0.46) | MEN1KMT2AALDH1A1GAALMNA | |
| SCHEMBL1609999 | 0.85 | ALOX5 (0.34) | ALDH1A1LMNAMAPTHTTSMN1; SMN2 | |
| SCHEMBL1609969 | 0.83 | CHRM3 (0.38) | ALDH1A1LMNAMAPTHTTSMN1; SMN2 | |
| SCHEMBL1610486 | 0.81 | SMN1; SMN2 (0.34) | MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL1609106 | 0.80 | TRPM8 (0.37) | MEN1KMT2AALDH1A1GAALMNA | |
| SCHEMBL1609271 | 0.79 | KLKB1 (0.34) | KMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL1609469 | 0.77 | PDE4D (0.36) | MEN1KMT2AALDH1A1GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086759-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086759-A1 | CHEMICAL COMPOUNDS | DDT, PNPO, CBR3 | MEN1 3860/4885KMT2A 2003/4885ALDH1A1 1562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.